Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitedomainvc.com
Twitter@domainvc
Phone609-683-5656
Employees
Founded1985

Funds

Eighth Fund, 4/2009

Offices

East Coast Office
One Palmer Square
Suite 515
Princeton, NJ, 08542
USA
San Diego, USA
12481 High Bluff Drive
Suite 150
San Diego, CA, 92130
USA

People

Partner
Partner
Partner
Partner
Partner
Partner
Partner & CFO
Founding Partner
Show All People

Tags

Domain Associates

Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on life sciences. With $2 billion of capital under management, Domain is headquartered in Princeton, NJ with a second office in San Diego, CA.

Domain’s three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices, while additional areas of interest include biomaterials, bioinstrumentation, and diagnostics. The Partners of Domain have a total of close to 200 person-years of experience among them in the healthcare/venture capital industries and have been involved in the formation and growth of more than 200 life-sciences companies. The highly focused network, experience, and reputation of this team have made it one of the top private-equity groups participating in the healthcare field.

Recent Milestones

Investments

Company Date Round Size Participants
Sequent Medical 4/2014Series D$20M4
Miramar Labs 2/2014Series D$10M5
Lithera 2/2014Series C$8M3
Atara Biotherapeutics 1/2014Series B$13.5M7
Atara Biotherapeutics 12/2013Series B$38.5M6
Xagenic 12/2013Series B$20M3
RightCare Solutions 11/2013Series B$5M2
NovaDigm Therapeutics 10/2013Series B$14M2
BioNano Genomics 10/2013Venture Round$10M3
Otonomy 9/2013Series C$45.9M8
Syndax Pharmaceuticals 8/2013Series B$26.6M4
Applied Proteomics 8/2013Series C$28M3
Dicerna Pharmaceuticals 7/2013Series C$60M9
ReVision Optics 7/2013Private Equity$55M6
aTyr Pharma 7/2013Series D$49M4
Veracyte 6/2013Series C$28M5
Esperion Therapeutics 4/2013Venture Round$33M7
Pinta Biotherapeutics* 4/2013Venture Round$4.29M1
Afferent Pharmaceuticals 4/2013Venture Round$5M2
Pinta Biotherapeutics* 3/2013Venture Round$1.01M1
Achaogen 3/2013Private Equity$18.9M7
Glaukos 2/2013Series F$30M7
Marinus Pharmaceuticals 1/2013Series C$21M4
Lithera 12/2012Series C$20.6M5
Regado Biosciences 12/2012Series E$51M8
Kona Medical 12/2012Series C$10M5
Epic Sciences 11/2012Series B$13M3
RightCare Solutions 10/2012Series A$1.75M2
Cotera 10/2012Venture Round$5.04M3
Veracyte 10/2012Private Equity$15M2
ROX Medical 9/2012Venture Round$6M2
CoDa Therapeutics 7/2012Series B$20M3
BioNano Genomics 7/2012Series B$10M3
Adynxx 7/2012Private Equity$2M1
Benvenue Medical 6/2012Series D$25M4
Twelve 6/2012Venture Round$15M3
Astute Medical 6/2012Series C$40.4M6
Kona Medical 5/2012Series C$30M4
Zyga Technology 5/2012Series C$25M4
Sequent Medical 3/2012Series C$26M4
Apnex Medical 2/2012Series C$20M3
Carticept Medical 1/2012Series C$10M3
Ariosa Diagnostics, Inc. 1/2012Series C$52.7M3
Afferent Pharmaceuticals 1/2012Venture Round$5M2
Kalidex Pharmaceuticals 1/2012Venture Round$6.5M6
IntegenX 12/2011Series C$40M7
Sera Prognostics 11/2011Series A$19.3M5
CoLucid Pharmaceuticals 8/2011Venture Round$7.5M5
Benvenue Medical 4/2011Series C$35.5M3
CoDa Therapeutics 4/2011Series B$19.2M3
BioNano Genomics 3/2011Series B$23.3M4
Astute Medical 3/2011Series B$13M4
IntegenX 2/2011Series B$15.6M3
aTyr Pharma 10/2010Series C$23M4
CellBiosciences 10/2010Series F$20M8
Tobira Therapeutics 9/2010Series B$31M5
Eddingpharm (Cayman) 9/2010Series B$24M3
Celator Pharmaceuticals 9/2010Series D$20M7
Otonomy 8/2010Series B$38.5M4
Achillion Pharmaceuticals 8/2010Venture Round$50.1M4
Nuon Therapeutics 8/2010Venture Round$10M3
ReVision Optics 7/2010Series D$35M4
Zogenix 7/2010Venture Round$15M5
Corridor Pharmaceuticals 6/2010Series A$13M8
Veracyte 6/2010Series B$28M4
Sequent Medical 5/2010Series B$15.6M3
Astute Medical 5/2010Series B$26.5M4
Tragara 4/2010Series B$5M5
Achaogen 4/2010Series C$56M7
Nuon Therapeutics 3/2010Venture Round$6.05M3
Syndax Pharmaceuticals 3/2010Series A$9M5
Carticept Medical 3/2010Series B$20M3
Altair Therapeutics 2/2010Series B$17M4
VentiRx Pharmaceuticals 1/2010Series A$51.6M4
Regado Biosciences 12/2009Series D$40M5
Afferent Pharmaceuticals 12/2009Series A$23M4
Apnex Medical 12/2009Series B$14M3
IntegenX 11/2009Series B$18.1M5
Zogenix 10/2009Series B$36M5
Alimera Sciences 10/2009Series C$5M5
Oraya Therapeutics 7/2009Series C$42M4
Clovis Oncology 5/2009Private Equity$145M7
Marinus Pharmaceuticals 5/2009Series B$20M4
CellBiosciences 4/2009Series C$10M7
BiPar Sciences 1/2009Series C$20M6
Glaukos 8/2008Series D$35M7
Neuron Systems 8/2008Series A$8.96M2
GenVault 6/2008Series C$13M4
Esperion Therapeutics 5/2008Series A$22.8M4
Nuon Therapeutics 4/2008Series B$27M2
BioVascular 2/2008Series C$10.9M3
Sonexa Therapeutics 1/2008Series A$30M5
Zogenix 1/2008Venture Round$18M4
Corthera 12/2007Series C$23M3
DiObex 4/2007Series B$24M6
GenVault 4/2007Venture Round$18M2
Regado Biosciences 3/2007Series C$23M3
BiPar Sciences 2/2007Series B$35M6
Achaogen 10/2006Series B$26M5
CoDa Therapeutics 10/2006Series A$10M1
Zogenix 8/2006Series A$60M5
CellBiosciences 1/2006Series B$27M8
Celladon 12/2005Series B$30M4
Alimera Sciences 11/2005Series B$31.8M5
DiObex 9/2005Venture Round$7.08M3
Five Prime Therapeutics 2/2005Venture Round$45M10
Glaukos 9/2002Series A$10M3

Videos

Sources

  1. PeHub (pehub.com) [edit]
  2. Sequent Medical Closes $20M Series D VC Financing (finsmes.com) [edit]
  3. Miramar Labs Raises $10M in Series D Funding (finsmes.com) [edit]
  4. Lithera Raises $8M in Series C Funding (finsmes.com) [edit]
  5. Atara Biotherapeutics Holds $13.5M Second Close of Series B FINANCING (finsmes.com) [edit]
  6. Atara Biotherapeutics Secures $38.5M in Series B Financing (finsmes.com) [edit]
  7. Xagenic Closes $20 Million Series B Financing (finsmes.com) [edit]
  8. RightCare Solutions Secures $5M in Series B Funding (finsmes.com) [edit]
  9. NovaDigm Therapeutics Closes $14M Series B Financing (finsmes.com) [edit]
  10. BioNano Genomics Raises $10M from Venture Investors (xconomy.com) [edit]
  11. Otonomy completes $45.9m Series C financing (finsmes.com) [edit]
  12. Syndax Pharmaceuticals Secures $26.6M Series B Financing (finsmes.com) [edit]
  13. Applied Proteomics Closes $28M Series C Financing (finsmes.com) [edit]
  14. Dicerna Pharmaceuticals Raises $60M In Series C Financing (finsmes.com) [edit]
  15. ReVision Optics Raises $55M In Equity Financing (finsmes.com) [edit]
  16. aTyr Pharma Completes $49M Equity Financing (finsmes.com) [edit]
  17. Veracyte Completes $28 Million Series C Financing (finsmes.com) [edit]
  18. Esperion Therapeutics Completes $33 Million Preferred Financing to Advance Its Novel Oral LDL-C Lowering Therapy to Later Stage Clinical Trials (businesswire.com) [edit]
  19. Pinta Biotherapeutics (venturedeal.com) [edit]
  20. VC Funding: Q2 2013 source [edit]
  21. Nina Biotherapeutics (venturedeal.com) [edit]
  22. VC Funding - Q2 2013 [edit]
  23. Glaukos Spots $30M for Eyeball Stent, Doesn't Blink in Ivantis Rivalry (pevc.dowjones.com) [edit]
  24. Marinus Pharmaceuticals Raises $21M Funding in Series C Financing (finsmes.com) [edit]
  25. Lithera, Inc. Completes $20.6 Million Equity Financing (lithera.com) [edit]
  26. Regado Biosciences, Inc. Secures $51 Million Series E Financing (regadobio.investorroom.com) [edit]
  27. Kona Medical raises $10 million in new Series C funding (bizjournals.com) [edit]
  28. Epic Sciences Completes $13M Series B Equity Financing (finsmes.com) [edit]
  29. RightCare Solutions Raises $1.75M Series A Financing Round (sg.finance.yahoo.com) [edit]
  30. VC funding: Q4 2012 [edit]
  31. VC funding: Q4 2012 [edit]
  32. ROX Medical Grabs Another $6M for Hypertension Therapy (pevc.dowjones.com) [edit]
  33. CoDa Therapeutics Raises $20M in Second Closes Series B Financing (finsmes.com) [edit]
  34. BioNano Genomics Adds $10M to Series B (pevc.dowjones.com) [edit]
  35. VC Funding: Q3 2012 source [edit]
  36. Benvenue Medical Secures $25 Million Series D Financing (sacbee.com) [edit]
  37. SEC (sec.gov) [edit]
  38. Astute Medical Completes $40.4M Series C Financing (finsmes.com) [edit]
  39. Kona Medical Raises $30M in Series C Financing (finsmes.com) [edit]
  40. Zyga Stacks Up $25M Series C To Test, Sell Joint Devices (pevc.dowjones.com) [edit]
  41. Sequent Medical Announces Closing of $26.0 Million Venture Financing (marketwatch.com) [edit]
  42. Apnex Medical, Inc.: Series C $20M (onbiovc.com) [edit]
  43. Carticept Medical Closes $10M Financing (finsmes.com) [edit]
  44. Aria Diagnostics Secures $52.7 Million in Oversubscribed Series C Financing (ariadx.com) [edit]
  45. VC Funding: Q1 2012 [edit]
  46. VC Funding: Q1 2012 [edit]
  47. IntegenX Garners $40,000,000 Series C Financing Round (xconomy.com) [edit]
  48. Sera Secures $19.3 million Financing; Appoints Greg C. Critchfield, MD as Chief Executive Officer (seraprognostics.com) [edit]
  49. CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million (prnewswire.com) [edit]
  50. Benvenue Medical raises $35.5M (bizjournals.com) [edit]
  51. CoDa Therapeutics Inks $19.2M Series B (pehub.com) [edit]
  52. BioNanomatrix Secures $23.3 Million in Series B Financing (bionanogenomics.com) [edit]
  53. Astute Medical Completes $13 Million Financing With Existing Stockholders (money.msn.com) [edit]
  54. Microsample Prep Company IntegenX Inc. Raises $15.6M, Acquires GenVault Corporation (integenx.wpengine.com) [edit]
  55. aTyr Pharma Secures $23M Financing From Top Tier Venture Investor (atyrpharma.com) [edit]
  56. Cell Biosciences Nabs $20M (xconomy.com) [edit]
  57. Tobira Therapeutics Inc. Raises $31 Million in Series B Financing (tobiratherapeutics.com) [edit]
  58. Eddingpharm (Cayman) Closes $24M Series B Funding (finsmes.com) [edit]
  59. CELATOR® PHARMACEUTICALS RAISES $20 MILLION IN SERIES D FINANCING (celatorpharma.com) [edit]
  60. Otonomy Closes $38.5 Million Series B Financing (otonomy.com) [edit]
  61. Achillion Announces Private Placement of $50 Million (ir.achillion.com) [edit]
  62. Nuon Therapeutics raises $10M in new funding (bizjournals.com) [edit]
  63. ReVision Optics, Inc.: Series D $35M (onbiovc.com) [edit]
  64. Zogenix Secures $35 Million Debt Facility And Raises $15 Million Investment Capital (zogenix.com) [edit]
  65. SEC (sec.gov) [edit]
  66. Veracyte, Inc.: Series B $28M (onbiovc.com) [edit]
  67. Sequent Medical, Inc.: Series B $15.6M (onbiovc.com) [edit]
  68. Astute Medical, Inc.: Series B $26.5M (onbiovc.com) [edit]
  69. Tragara Pharmaceuticals, Inc.: Series B $5M (onbiovc.com) [edit]
  70. Achaogen Completes $56 Million Series C Financing (pr-inside.com) [edit]
  71. Nuon captures $6.05M to develop treatments for autoimmune disease (venturebeat.com) [edit]
  72. Syndax Pharmaceuticals, Inc.: Series A $9M (onbiovc.com) [edit]
  73. AltAssets (altassets.com) [edit]
  74. Altair Therapeutics, Inc.: Series B $17M (onbiovc.com) [edit]
  75. VentiRx Pharma Extends Series A To $51.6M (fis.dowjones.com) [edit]
  76. Regado Biosciences, Inc. Completes $40 Million Series D Financing (regadobio.com) [edit]
  77. Afferent Pharmaceuticals Closes $23M Series A Financing Round (finsmes.com) [edit]
  78. Apnex Medical, Inc. Raises Additional $14 Million (apnexmedical.com) [edit]
  79. Microchip Biotechnologies Raises $18.1M in Series B Financing (sanfrancisco.bizjournals.com) [edit]
  80. SEC D (sec.gov) [edit]
  81. Alimera Sciences, Inc.: Series C $5M (onbiovc.com) [edit]
  82. Oraya garners $42M in third venture round (fiercebiotech.com) [edit]
  83. Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development (onbiovc.com) [edit]
  84. Marinus Pharmaceuticals, Inc.: Series B $20M (onbiovc.com) [edit]
  85. Cell Biosciences Raises $10 Million (pehub.com) [edit]
  86. BiPar Sciences Raises $20 Million to Advance Clinical Programs (biparsciences.com) [edit]
  87. Glaukos Adds $35 Million (equityhelpdesk.com) [edit]
  88. Equity Help Desk (equityhelpdesk.com) [edit]
  89. Capital Funding Report [edit]
  90. Esperion Therapeutics Completes $22.75M Series A Financing (esperion.com) [edit]
  91. Nuon Therapeutics, Inc. Completes $27 Million Series B Financing (nuontherapeutics.com) [edit]
  92. BioVascular Inc. Closes $10.87 Million Series C Financing (salesandmarketingnetwork.com) [edit]
  93. Sonexa Therapeutics, Inc. Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments (biospace.com) [edit]
  94. Zogenix Raises $18 Million in Preferred Stock Financing (zogenix.com) [edit]
  95. Corthera Closes $23 Million Financing Round (basmedical.com) [edit]
  96. DiObex, a metabolic disease treatment co., raises $24M (venturebeat.com) [edit]
  97. GenVault Corporation Raises $18 Million of Financing (genvault.com) [edit]
  98. REGADO BIOSCIENCES COMPLETES $23 MILLION SERIES C FINANCING (regadobio.investorroom.com) [edit]
  99. BiPar Sciences Raises $35 Million to Advance Pipeline of Novel PARP Inhibitor Cancer Drug Candidates (biparsciences.com) [edit]
  100. Achaogen Closes Series B Financing (achaogen.com) [edit]
  101. CoDa Therapeutics Announces Series A Financing (codatherapeutics.com) [edit]
  102. Zogenix, Inc. Raises $60 Million In Series A Venture Financing; Names Board of Directors (zogenix.com) [edit]
  103. Bio-Medicine (bio-medicine.org) [edit]
  104. Celladon Secures $30 Million in Series B Financing. (thefreelibrary.com) [edit]
  105. Alimera Sciences Secures $31.8 Million in Series B Financing (gabio.org) [edit]
  106. EDGAR [edit]
  107. Five Prime Therapeutics, Inc. Raises $45MM in Private Financing (fiveprime.com) [edit]
  108. Glaukos Receives Series A Investment From Domain Associates, LLC, Versant Ventures, And Frazier Healthcare Ventures (privco.com) [edit]
Edit This Page
Last Edited 4/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy